
Reset all filters
01 6Revatio
02 2Sildenafil Citrate
03 4Total Viagra
04 5Viagra
05 1Viagra EH
06 2Viagra Eh
07 1Viagra GEP
08 1Viagra GIP
09 1Viagra IH
10 2Viagra Ih
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 144
2018 Revenue in Millions : 227
Growth (%) : -37
Main Therapeutic Indication : Urology
Currency : USD
2019 Revenue in Millions : 497
2018 Revenue in Millions : 636
Growth (%) : -22
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 459
2021 Revenue in Millions : 534
Growth (%) : -14
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 429
2022 Revenue in Millions : 459
Growth (%) : -7
Main Therapeutic Indication : Sexual Health
Currency : USD
2014 Revenue in Millions : -10.40%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Sexual Health
Currency : USD
2015 Revenue in Millions : 1,181
2014 Revenue in Millions : 1,297
Growth (%) : 10%
Main Therapeutic Indication : Antihypertensives
Currency : USD
2014 Revenue in Millions : -10.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Sexual Health
Currency : USD
2015 Revenue in Millions : 504
2014 Revenue in Millions : 411
Growth (%) : -18%
Main Therapeutic Indication : Antihypertensives
Currency : USD
2015 Revenue in Millions : 276
2014 Revenue in Millions : 260
Growth (%) : -6%
Main Therapeutic Indication : Sexual Health
Currency : USD
2015 Revenue in Millions : 1,685
2014 Revenue in Millions : 1,708
Growth (%) : 1%